Your browser doesn't support javascript.
loading
Results of a single-arm pilot study of 32P microparticles in unresectable locally advanced pancreatic adenocarcinoma with gemcitabine/nab-paclitaxel or FOLFIRINOX chemotherapy.
Ross, P J; Wasan, H S; Croagh, D; Nikfarjam, M; Nguyen, N; Aghmesheh, M; Nagrial, A M; Bartholomeusz, D; Hendlisz, A; Ajithkumar, T; Iwuji, C; Wilson, N E; Turner, D M; James, D C; Young, E; Harris, M T.
Affiliation
  • Ross PJ; Guy's & St Thomas' Hospital NHS Foundation Trust, London, UK. Electronic address: paul.ross@gstt.nhs.uk.
  • Wasan HS; Imperial College Healthcare NHS Trust, London, UK.
  • Croagh D; Monash Health, Clayton, Australia.
  • Nikfarjam M; Austin Hospital, University of Melbourne, Australia.
  • Nguyen N; Royal Adelaide Hospital, Adelaide, Australia.
  • Aghmesheh M; Southern Medical Day Care Centre, Wollongong, Australia.
  • Nagrial AM; The Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, Australia.
  • Bartholomeusz D; Royal Adelaide Hospital, Adelaide, Australia.
  • Hendlisz A; Institut Jules Bordet, Brussels, Belgium.
  • Ajithkumar T; Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Iwuji C; Leicester Royal Infirmary, University Hospitals of Leicester NHS Trust, Leicester, UK.
  • Wilson NE; OncoSil Medical Limited, Sydney, Australia.
  • Turner DM; OncoSil Medical Limited, Sydney, Australia.
  • James DC; OncoSil Medical Limited, Sydney, Australia.
  • Young E; Southern Star Research Pty Ltd, Gordon, Australia.
  • Harris MT; Monash Health, Clayton, Australia.
ESMO Open ; 7(1): 100356, 2022 02.
Article in En | MEDLINE | ID: mdl-34953400

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Adenocarcinoma Type of study: Guideline / Prognostic_studies Limits: Adult / Humans Language: En Journal: ESMO Open Year: 2022 Document type: Article Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Adenocarcinoma Type of study: Guideline / Prognostic_studies Limits: Adult / Humans Language: En Journal: ESMO Open Year: 2022 Document type: Article Country of publication: